Thursday, September 15, 2022 - 11 a.m. to noon
UNH Franklin Pierce School of Law
Companies have spent billions developing vaccines for Covid-19 to address the global pandemic. Moderna was applauded for its October, 2020 patent pledge to not enforce any of its Covid-19 related patents during the pandemic. Is it fair for them to do so now?
Please join us for a discussion of the implications of the recent patent suit filed by Moderna against Pfizer. We will explore the following with our panelists Richard Kurz (Adjunct Professor, Partner Haug Partners LLC, ’10) and Bruce Leicher (Adjunct Professor, consultant and former General Counsel of Momenta Pharmaceuticals), moderated by Micky Minhas ’97 (Director of Intellectual Property). Introductions by Lucy Hodder (Professor of Law, Director of Health Law and Policy).
